未登录

L

Liying Ma

National Institutes for Food and Drug Control

H指数:22

被引数:2,471

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Multicomponent exercise interventions for cognitive function in patients with mild cognitive impairment: a summary of best evidence

多成分运动干预对轻度认知障碍患者认知功能的影响：最佳证据总结

Frontiers in Rehabilitation Sciences

IF1.9

2025-12-191

OAAI

Fufang Shuanghua oral liquid alleviates influenza A virus-infected acute lung injury by restoring antiviral immunity partially via TNF-mediated IFN/NLRP3-inflammasome signaling

复方双花口服液通过部分经TNF介导的IFN/NLRP3炎症小体信号通路恢复抗病毒免疫，减轻甲型流感病毒感染的急性肺损伤

Journal of Ethnopharmacology

IF5.4

2025-07-200

PRE

Innovative medicinal chemistry strategies for enhancing drug solubility

提高药物溶解度的创新药物化学策略

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2024-12-011

PRE

Improving Anti-HIV activity and pharmacokinetics of enfuvirtide (T20) by modification with oligomannose

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2024-04-010

PRE

Glycan-Modified Peptides for Dual Inhibition of Human Immunodeficiency Virus Entry into Dendritic Cells and T Cells

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2024-02-160

PRE

Incidence of low-level viremia and its impact on virologic failure among people living with HIV who started an integrase strand transfer inhibitors: a longitudinal cohort study

BMC INFECTIOUS DISEASES

IF3

2024-01-022

OAAI

Broad-spectrum anti-HIV activity and high drug resistance barrier of lipopeptide HIV fusion inhibitor LP-19

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-05-156

OAAI

The influence of polycystic ovary syndrome on abortion rate after in vitro fertilization/intracytoplasmic sperm injection fresh cycle pregnancy

SCIENTIFIC REPORTS

IF3.9

2023-04-121

OAAI

Darinaparsin (ZIO-101) enhances the sensitivity of small-cell lung cancer to PARP inhibitors

ACTA PHARMACOLOGICA SINICA

IF8.4

2022-10-173

PRE

Application of high-throughput sequencing technology in HIV drug resistance detection

BIOSAFETY AND HEALTH

IF3

2021-10-016

OAAI

Virus Evolution and Neutralization Sensitivity in an HIV-1 Subtype B′ Infected Plasma Donor with Broadly Neutralizing Activity

IF3.4

2021-03-258

OAAI

Increase in HIV-1-transmitted drug resistance among ART-naive youths at the China-Myanmar border during 2009 ∼ 2017

BMC INFECTIOUS DISEASES

IF3

2021-01-2112

OAAI

The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer (vol 39, 219, 2020)

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2021-01-055

OAAI

The MYC Paralog-PARP1 Axis as a Potential TherapeuticTarget in MYC Paralog-Activated Small Cell Lung Cancer

FRONTIERS IN ONCOLOGY

IF3.3

2020-10-088

OAAI

Polyethylene Glycol 40-Modified Peptide with High Therapeutic Efficacy in Simian-Human Immunodeficiency Virus-Acutely Infected Rhesus Monkeys

JOURNAL OF VIROLOGY

IF3.8

2020-07-011

OAAI

Rapid Elimination of Broadly Neutralizing Antibodies Correlates with Treatment Failure in the Acute Phase of Simian-Human Immunodeficiency Virus Infection

JOURNAL OF VIROLOGY

IF3.8

2019-10-156

OAAI

Long-Acting HIV-1 Fusion Inhibitory Peptides and their Mechanisms of Action

IF3.5

2019-09-0214

OAAI

Characteristics of Envelope Genes in a Chinese Chronically HIV-1 Infected Patient With Broadly Neutralizing Activity

FRONTIERS IN MICROBIOLOGY

IF4.5

2019-05-246

OAAI

Disparate impact on CD4 T cell count by two distinct HIV-1 phylogenetic clusters from the same Glade

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2018-12-1743

OAAI

A defucosylated bispecific multivalent molecule exhibits broad HIV-1-neutralizing activity and enhanced antibody-dependent cellular cytotoxicity against reactivated HIV-1 latently infected cells

IF3.1

2018-08-2412

OAAI